Sandhill Capital Partners LLC Catalent, Inc. Transaction History

Sandhill Capital Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$41.39 - $81.0 $10.2 Million - $20 Million	-246,962 Reduced 97.8%	5,560 $250,000
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $1.89 Million - $2.95 Million	-26,077 Reduced 9.36%	252,522 $18.3 Million
Q2 2022 Aug 10, 2022	SELL	$87.2 - $114.05 $3.68 Million - $4.82 Million	-42,223 Reduced 13.16%	278,599 $29.9 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $1.78 Million - $2.35 Million	18,845 Added 6.24%	320,822 $35.6 Million
Q4 2021 Feb 09, 2022	SELL	$119.57 - $139.07 $1.86 Million - $2.17 Million	-15,570 Reduced 4.9%	301,977 $38.7 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $34.7 Million - $45.2 Million	317,547 New	317,547 $42.3 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Sandhill Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Sandhill Capital Partners LLC with notifications on news.